Healthcare Provider Discrimination toward Pregnant Women with Rifampin-Resistant Tuberculosis
Little is known about the treatment experiences of pregnant women with rifampin-resistant tuberculosis. We conducted qualitative interviews with 10 women who had this condition; 9 reported facing discrimination from healthcare providers. Our findings underscore an urgent need to ensure a human-right...
Main Authors: | Marian Loveday, Sindisiwe Hlangu, Jennifer Furin |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2019-03-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/25/3/18-1571_article |
Similar Items
-
Discordance in Mycobacterium tuberculosis Rifampin Susceptibility
by: Ameeta S. Kalokhe, et al.
Published: (2012-03-01) -
rpoB Mutations and Effects on Rifampin Resistance in Mycobacterium tuberculosis
by: Li M, et al.
Published: (2021-10-01) -
Etymologia: Rifampin
by: Ronnie Henry
Published: (2018-03-01) -
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in <it>Mycobacterium tuberculosis</it>
by: Parsons Linda M, et al.
Published: (2001-04-01) -
Rifampin- or Capreomycin-Induced Remodeling of the Mycobacterium smegmatis Mycolic Acid Layer Is Mitigated in Synergistic Combinations with Cationic Antimicrobial Peptides
by: DeDe Kwun-Wai Man, et al.
Published: (2018-07-01)